Search

everythinglearnresearchcommunity

for

Search:↓

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Tofacitinib taken by mouth helps treat hair loss in children.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Upadacitinib may effectively treat alopecia areata without side effects.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Tofacitinib helped a woman regrow hair with no major side effects.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

The rash resolved after stopping ponatinib.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Tofacitinib might be used to treat hair loss.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.